StockData
PERRIGO Co plc logo

PERRIGO Co plc (PRGO) stock

PRGONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3028% below fair value
$16.94+1.18 (+7.49%)

Close on Nov 18, 2026Market cap $2.35BP/E –Yield 6.85%

Perrigo free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Perrigo's free cash flow for the twelve months ending Jun 27, 2026 was $119.30M, down 53.5% year over year. For fiscal 2025 it was $145.10M, down 40.7% from the year before. Over ten years it grew -10.9% a year on average. The highest annual figure on record is $718.20M in fiscal 2015.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$145.10M-40.7%
FY2024Dec 31, 2024$244.60M-19.5%
FY2023Dec 31, 2023$303.80M+44.0%
FY2022Dec 31, 2022$210.90M+4921.4%
FY2021Dec 31, 2021$4.20M-99.1%
FY2020Dec 31, 2020$465.80M+86.2%
FY2019Dec 31, 2019$250.10M-49.0%
FY2018Dec 31, 2018$490.40M-19.6%
FY2017Dec 31, 2017$610.30M-15.0%
FY2015Jun 27, 2015$718.20M+55.7%
FY2014Jun 28, 2014$461.40M+2.6%
FY2013Jun 29, 2013$449.70M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 27, 2026$68.30M+20.5%
Q1 FY2026CQ1 2026Mar 28, 2026-$127.40M–
Q4 FY2025CQ4 2025Dec 31, 2025$148.60M-45.9%
Q3 FY2025CQ3 2025Sep 27, 2025$29.80M+97.4%
Q2 FY2025CQ2 2025Jun 28, 2025$56.70M–
Q1 FY2025CQ1 2025Mar 29, 2025-$90.00M–
Q4 FY2024CQ4 2024Dec 31, 2024$274.90M+51.0%
Q3 FY2024CQ3 2024Sep 28, 2024$15.10M-83.7%
Q2 FY2024CQ2 2024Jun 29, 2024-$18.90M-157.4%
Q1 FY2024CQ1 2024Mar 30, 2024-$26.50M–
Q4 FY2023CQ4 2023Dec 31, 2023$182.00M+14.1%
Q3 FY2023CQ3 2023Sep 30, 2023$92.70M+144.6%
Q2 FY2023CQ2 2023Jul 1, 2023$32.90M–
Q1 FY2023CQ1 2023Apr 1, 2023-$3.80M-106.5%
Q4 FY2022CQ4 2022Dec 31, 2022$159.50M–
Q3 FY2022CQ3 2022Oct 1, 2022$37.90M-87.4%
Q2 FY2022CQ2 2022Jul 2, 2022-$45.30M–
Q1 FY2022CQ1 2022Apr 2, 2022$58.80M–
Q4 FY2021CQ4 2021Dec 31, 2021-$147.10M-432.1%
Q3 FY2021CQ3 2021Oct 2, 2021$301.80M+1496.8%
Q2 FY2021CQ2 2021Jul 3, 2021-$105.30M-139.8%
Q1 FY2021CQ1 2021Apr 3, 2021-$45.20M-132.8%
Q4 FY2020CQ4 2020Dec 31, 2020$44.30M+5.2%
Q3 FY2020CQ3 2020Sep 26, 2020$18.90M-81.9%
Q2 FY2020CQ2 2020Jun 27, 2020$264.60M+776.2%
Q1 FY2020CQ1 2020Mar 28, 2020$138.00M+88.0%
Q4 FY2019CQ4 2019Dec 31, 2019$42.10M-71.6%
Q3 FY2019CQ3 2019Sep 28, 2019$104.40M-13.4%
Q2 FY2019CQ2 2019Jun 29, 2019$30.20M-51.6%
Q1 FY2019CQ1 2019Mar 30, 2019$73.40M-53.8%
Q4 FY2018CQ4 2018Dec 31, 2018$148.50M-19.1%
Q3 FY2018CQ3 2018Sep 29, 2018$120.50M-32.6%
Q2 FY2018CQ2 2018Jun 30, 2018$62.40M-17.5%
Q1 FY2018CQ1 2018Mar 31, 2018$159.00M-7.8%
Q4 FY2017CQ4 2017Dec 31, 2017$183.50M+194.1%
Q3 FY2017CQ3 2017Sep 30, 2017$178.70M+20.5%
Q2 FY2017CQ2 2017Jul 1, 2017$75.60M–
Q1 FY2017CQ1 2017Apr 1, 2017$172.50M–
Q4 FY2015CQ2 2015Jun 27, 2015$62.40M–
Q3 FY2015CQ1 2015Mar 28, 2015$148.30M–

More Perrigo figures

See a number that looks wrong?